Quantitative comparison of SARS-CoV-2 nucleic acid amplification test and antigen testing algorithms: a decision analysis simulation model

Background Antigen tests for SARS-CoV-2 offer advantages over nucleic acid amplification tests (NAATs, such as RT-PCR), including lower cost and rapid return of results, but show reduced sensitivity. Public health organizations recommend different strategies for utilizing NAATs and antigen tests. We sought to create a framework for the quantitative comparison of these recommended strategies based on their expected performance. Methods We utilized a decision analysis approach to simulate the expected outcomes of six testing algorithms analogous to strategies recommended by public health organizations. Each algorithm was simulated 50,000 times in a population of 100,000 persons seeking testing. Primary outcomes were number of missed cases, number of false-positive diagnoses, and total test volumes. Outcome medians and 95% uncertainty ranges (URs) were reported. Results Algorithms that use NAATs to confirm all negative antigen results minimized missed cases but required high NAAT capacity: 92,200 (95% UR: 91,200-93,200) tests (in addition to 100,000 antigen tests) at 10% prevalence. Selective use of NAATs to confirm antigen results when discordant with symptom status (e.g., symptomatic persons with negative antigen results) resulted in the most efficient use of NAATs, with 25 NAATs (95% UR: 13-57) needed to detect one additional case compared to exclusive use of antigen tests. Conclusions No single SARS-CoV-2 testing algorithm is likely to be optimal across settings with different levels of prevalence and for all programmatic priorities. This analysis provides a framework for selecting setting-specific strategies to achieve acceptable balances and trade-offs between programmatic priorities and resource constraints.

Proposed Standard Test Protocols and Outcome Measures for Quantitative Comparison of Emissions from Electronic Nicotine Delivery Systems

This study introduces and demonstrates a comprehensive, accurate, unbiased approach to robust quantitative comparison of Electronic Nicotine Delivery Systems (ENDS) appropriate for establishing substantial equivalence (or lack thereof) between tobacco products. The approach is demonstrated across a family of thirteen pen- and pod-style ENDS products. Methods employed consist of formulating a robust emissions surface regression model, quantifying the empirical accuracy of the model as applied to each product, evaluating relationships between product design characteristics and maximum emissions characteristics, and presenting results in formats useful to researchers, regulators, and consumers. Results provide a response surface to characterize emissions (total particulate matter and constituents thereof) from each ENDS appropriate for use in a computer model and for conducting quantitative exposure comparisons between products. Results demonstrate that emissions vary as a function of puff duration, flow rate, E-Liquid composition, and device operating power. Further, results indicate that regulating design characteristics of ENDS devices and consumables may not achieve desired public health outcomes; it is more effective to regulate maximum permissible emissions directly. Three emissions outcome measures (yield per puff, mass concentration and constituent mass ratio) are recommended for adoption as standard quantities for reporting by manufacturers and research laboratories. The approach provides a means of (a) quantifying and comparing maximal emissions from ENDS products spanning their entire operating envelope, (b) comparative evaluation of ENDS devices and consumable design characteristics, and (c) establishing comparative equivalence of maximal emissions from ENDS. A consumer-oriented product emissions dashboard is proposed for comparative evaluation of ENDS exposure potential. Maximum achievable power dissipated in the coil of ENDS is identified as a potentially effective regulatory parameter.

Towards Effective Patient Simulators

In this paper we give an overview of the field of patient simulators and provide qualitative and quantitative comparison of different modeling and simulation approaches. Simulators can be used to train human caregivers but also to develop and optimize algorithms for clinical decision support applications and test and validate interventions. In this paper we introduce three novel patient simulators with different levels of representational accuracy: HeartPole, a simplistic transparent rule-based system, GraphSim, a graph-based model trained on intensive care data, and Auto-ALS—an adjusted version of an educational software package used for training junior healthcare professionals. We provide a qualitative and quantitative comparison of the previously existing as well as proposed simulators.

Orthorectification of Skin Nevi Images by Means of 3D Model of the Human Body

Melanoma is the most lethal form of skin cancer, and develops from mutation of pigment-producing cells. As it becomes malignant, it usually grows in size, changes proportions, and develops an irregular border. We introduce a system for early detection of such changes, which enables whole-body screening, especially useful in patients with atypical mole syndrome. The paper proposes a procedure to build a 3D model of the patient, relate the high-resolution skin images with the model, and orthorectify these images to enable detection of size and shape changes in nevi. The novelty is in the application of image encoding indices and barycentric coordinates of the mesh triangles. The proposed procedure was validated with a set of markers of a specified geometry. The markers were attached to the body of a volunteer and analyzed by the system. The results of quantitative comparison of original and corrected images confirm that the orthorectification allows for more accurate estimation of size and proportions of skin nevi.

Influência do uso de reveladores na viabilidade de microrganismos da placa dental

It was made a quantitative comparison between dental plaque of 15 patients in two moments, immediatly before and after the use of erythrosin 0,25% as a disclosing agent. The collected material was plated in AMS and the colonies counts, according to the Student's test, didn't show any significant difference. The patients didn't brush their teeth 24 before the colection of dental plaque in order to acumulate more deposit.

A simple cornea deformation model

In this paper, we present a cornea deformation model based on the idea of extending the ‘neutral axis’ model to two-dimensional deformations. Considering this simple model, assuming the corneal tissue to behave like a continuous, isotropic and non-compressible material, we are able to partially describe, e.g., the observed deviation in refractive power after lenticule extraction treatments. The model provides many input parameters of the patient and the treatment itself, leading to an individual compensation ansatz for different setups. The model is analyzed for a reasonable range of various parameters. A semi-quantitative comparison to real patient data is performed.